Viewing data from:

DESOXIMETASONE

ANDA

DESOXIMETASONE | A208101 | ENCUBE ETHICALS PRIVATE LTD

1 strength0 unique patents0 unique exclusivities

API Supply Chain5 active DMFs2 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

TARO PHARMACEUTICAL INDUSTRIES LTDDESOXIMETASONE USP

DMF 138611998

EUROAPI FRANCEDESOXIMETASONE USP, MICRONIZED

DMF 148522000

FARMABIOS SPADESOXIMETASONE

DMF 177592004

SYMBIOTEC PHARMALAB PRIVATE LTDDESOXIMETASONE USP (MICRONIZED)

DMF 224002009

TARO PHARMACEUTICAL INDUSTRIES LTDDESOXIMETASONE USP, MICRONIZED

DMF 268412013

SOCIETA ITALIANA CORTICOSTEROIDI SPAInactiveDESOXIMETASONE

DMF 74241988

TARO PHARMACEUTICAL INDUSTRIES LTDInactiveDESOXIMETASONE

DMF 110181994

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 0.25%

0 patents0 exclusivities▴

OINTMENT;TOPICAL | Approved: Feb 25, 2016

No patent or exclusivity listings for this strength.

Change History (2)

Recent changes detected for this application.

MODIFIEDApplicant7/1/2026

ENCUBE acquired applicant rights to desoximetasone NDA 208101 from PAI Holdings Pharm.

Old: PAI HOLDINGS PHARM

New: ENCUBE

MODIFIEDApplicant Full Name7/1/2026

ENCUBE ETHICALS PRIVATE LTD replaced PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC as the applicant for desoximetasone NDA 208101.

Old: PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC

New: ENCUBE ETHICALS PRIVATE LTD